Akèy › Ateroskleroz › Idaho › Meridian
Etid klinik pou Ateroskleroz nan Meridian, ID
5 etid pou Ateroskleroz ap chèche patisipan nan sit nan ak bò kote Meridian (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Ap rekriteFaz 3
- High Desert Heart & Vascular, Meridian
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Velocity Clinical Research - Boise, Meridian
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Ap rekriteFaz 2
- St. Luke's Clinic - Idaho Cardiology Associates, Meridian
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Ap rekriteFaz 3
- High Desert Heart & Vascular, Meridian
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Ap rekriteFaz 3
- Research Site, Meridian
Etid Ateroskleroz nan lòt vil
- Boston, MA10 etid
- Houston, TX10 etid
- Washington, DC9 etid
- Orlando, FL8 etid
- Arlington, VA8 etid
- Hialeah, FL8 etid
- Durham, NC7 etid
- Dallas, TX7 etid
- Memphis, TN7 etid
- Miami, FL7 etid
- Las Vegas, NV7 etid
- San Diego, CA6 etid
Lòt etid nan Meridian
- Obèsite8 etid
- Sipwa7 etid
- Kansè pwostat6 etid
- Leksemi mieloïd egi6 etid
- Kansè Poumon ki pa ti selil4 etid
- Kansè poumon4 etid
- Karsinòm selil skuamèz tèt ak kou3 etid
- Melanom3 etid
- Kansè ovè3 etid
- Ekzema3 etid
- Maladi kadyovaskilè3 etid
- Kansè kolon3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.